← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2020Last known activity
Sep 3, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 24 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (35)
- NCT07234110CollaboratorN/ASep 3, 2025
- NCT06886919OfficialEarly Phase 1Mar 31, 2025
- NCT06983951OfficialN/AFeb 20, 2025
- NCT06993493Lead sponsorN/AFeb 20, 2025
- NCT06983964Lead sponsorN/AFeb 20, 2025
- NCT06983964OfficialN/AFeb 20, 2025
- NCT06983951Lead sponsorN/AFeb 20, 2025
- NCT06993493OfficialN/AFeb 20, 2025
- NCT06661811Lead sponsorN/ANov 15, 2024
- NCT06661811OfficialN/ANov 15, 2024
- NCT06313957CollaboratorPhase 1Mar 14, 2024
- NCT05868967OfficialPhase 1Feb 27, 2023
- NCT05868967Overall official - principal investigatorPhase 1Feb 27, 2023
- NCT05675943Lead sponsorN/AJan 9, 2023
- NCT05477446CollaboratorPhase 1Oct 1, 2022
Details
- Last known activity
- Sep 3, 2025